No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3dyaB, 1.0000, 0.00, 1.000, 402, 402, HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1
2, 3ffiB, 0.9978, 0.34, 1.000, 403, 402, HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR
3, 3e01B, 0.9953, 0.34, 1.000, 401, 401, HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
4, 3m8pB, 0.9946, 0.39, 1.000, 401, 401, HIV-1 RT WITH NNRTI TMC-125
5, 2yniB, 0.9944, 0.55, 1.000, 404, 402, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK952
6, 4kv8B, 0.9943, 0.65, 0.998, 407, 402, CRYSTAL STRUCTURE OF HIV RT IN COMPLEX WITH BILR0355BS
7, 2yngB, 0.9941, 0.56, 1.000, 411, 402, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK560
8, 2ynhB, 0.9931, 0.61, 1.000, 406, 402, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK500
9, 3nbpB, 0.9901, 0.35, 1.000, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
10, 3tamB, 0.9897, 0.65, 0.997, 403, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M06
11, 3lakB, 0.9894, 0.41, 0.997, 403, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
12, 3lalB, 0.9893, 0.42, 0.997, 403, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
13, 3lanB, 0.9890, 0.44, 0.997, 403, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
14, 4i7fB, 0.9889, 0.45, 1.000, 405, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE
15, 2ynfB, 0.9888, 0.69, 1.000, 406, 401, HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR GSK560
16, 3m8qB, 0.9884, 0.29, 1.000, 398, 398, HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
17, 3di6B, 0.9884, 0.70, 0.997, 400, 399, HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
18, 3lamB, 0.9883, 0.48, 0.997, 403, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
19, 3drsB, 0.9881, 0.71, 0.997, 405, 400, HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
20, 3i0sB, 0.9877, 0.74, 1.000, 405, 400, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7
21, 4ncgB, 0.9872, 0.40, 1.000, 402, 398, DISCOVERY OF DORAVIRINE AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES
22, 2jleB, 0.9870, 0.93, 0.998, 415, 401, NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
23, 3drpB, 0.9866, 0.68, 1.000, 404, 399, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
24, 3i0rB, 0.9865, 0.76, 1.000, 405, 400, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3
25, 3c6tB, 0.9864, 0.68, 1.000, 404, 399, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14
26, 2rkiB, 0.9861, 0.48, 1.000, 402, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
27, 3mecB, 0.9858, 0.48, 1.000, 401, 398, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
28, 3c6uB, 0.9858, 0.72, 1.000, 404, 399, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22
29, 5k14B, 0.9855, 0.51, 1.000, 401, 398, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 26-DIFLUOROPHENYL DAPY ANALOG
30, 3t1aB, 0.9854, 0.61, 0.997, 400, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05
31, 3medB, 0.9854, 0.51, 0.997, 401, 398, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
32, 3meeB, 0.9851, 0.52, 1.000, 401, 398, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
33, 5vz6B, 0.9849, 0.62, 1.000, 400, 398, HIV REVERSE TRANSCRIPTASE COMPLEXED WITH (E)-3-(PYRIMIDIN-2-YL)-N-(5- (5;6;7;8-TETRAHYDRONAPHTHALEN-2-YL)-1H-PYRAZOL-3-YL)ACRYLAMIDE 
34, 3qipB, 0.9848, 0.54, 1.000, 402, 398, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE
35, 3drrB, 0.9847, 0.76, 0.997, 404, 399, HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
36, 3t19B, 0.9846, 0.65, 0.997, 400, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05
37, 3megB, 0.9846, 0.54, 0.997, 404, 398, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
38, 2rf2B, 0.9838, 0.87, 1.000, 405, 400, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
39, 1ikxB, 0.9837, 1.14, 0.973, 427, 401, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721
40, 3lp2B, 0.9836, 0.69, 0.997, 400, 398, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
41, 2wonB, 0.9824, 0.88, 0.992, 412, 398, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
42, 2womB, 0.9824, 0.88, 0.990, 412, 398, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
43, 3lp1B, 0.9822, 0.75, 0.997, 400, 398, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
44, 3lp0B, 0.9816, 0.76, 0.997, 400, 398, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
45, 1ikyB, 0.9806, 0.92, 0.980, 405, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194
46, 1ikwB, 0.9805, 0.92, 0.982, 405, 399, WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ
47, 2vg5B, 0.9783, 0.92, 0.995, 401, 397, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
48, 2yknB, 0.9775, 1.11, 0.990, 410, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
49, 1ikvB, 0.9774, 0.93, 0.982, 404, 398, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ
50, 2ykmB, 0.9759, 1.16, 0.990, 410, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
51, 2vg6B, 0.9730, 1.13, 0.995, 401, 397, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
52, 1eetB, 0.9730, 1.07, 0.982, 399, 396, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
53, 5hbmB, 0.9713, 1.37, 0.978, 413, 402, CRYSTAL STRUCTURE OF A DIHYDROXYCOUMARIN RNASE H ACTIVE-SITE INHIBITOR IN COMPLEX WITH HIV-1 REVERSE TRANSCRIPTASE
54, 4h4mB, 0.9712, 1.44, 0.985, 428, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
55, 1s9gB, 0.9710, 1.38, 0.970, 425, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
56, 4lslB, 0.9708, 1.28, 0.985, 417, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ476) A NON-NUCLEOSIDE INHIBITOR
57, 1tv6B, 0.9705, 1.18, 0.990, 411, 399, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94707
58, 4h4oB, 0.9703, 1.47, 0.985, 428, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH (E)-3-(3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)- 4- FLUOROPHENOXY)-5-FLUOROPHENYL)ACRYLONITRILE (JLJ506) A NON- NUCLEOSIDE INHIBITOR
59, 3kleJ, 0.9703, 1.21, 0.990, 419, 400, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
60, 1s9eB, 0.9698, 1.44, 0.985, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
61, 4mfbB, 0.9696, 1.36, 0.985, 413, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY) INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
62, 2i5jB, 0.9696, 1.27, 0.982, 420, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH AN RNASE H INHIBITOR
63, 2be2B, 0.9695, 1.48, 0.973, 426, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
64, 2b5jB, 0.9693, 1.28, 0.975, 427, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
65, 3jsmB, 0.9690, 1.21, 0.990, 413, 400, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
66, 3kleN, 0.9689, 1.24, 0.990, 419, 400, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
67, 2banB, 0.9689, 1.43, 0.978, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
68, 3jytB, 0.9687, 1.22, 0.985, 413, 400, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS- DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
69, 1suqB, 0.9687, 1.44, 0.985, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
70, 5c42B, 0.9685, 1.49, 0.985, 424, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K101P) VARIANT IN COMPLEX WITH 8-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
71, 2vg7B, 0.9685, 1.01, 0.992, 395, 394, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
72, 1rtdB, 0.9679, 1.26, 0.992, 414, 400, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
73, 1s6qB, 0.9678, 1.32, 0.985, 427, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
74, 1sv5B, 0.9673, 1.40, 0.973, 427, 401, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
75, 4q0bD, 0.9671, 1.27, 0.992, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
76, 4lsnB, 0.9669, 1.39, 0.983, 416, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-BROMO-5-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ518) A NON-NUCLEOSIDE INHIBITOR
77, 4pwdD, 0.9668, 1.27, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
78, 4q0bB, 0.9666, 1.28, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
79, 5tw3B, 0.9665, 1.23, 0.985, 409, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)-4-FLUOROPHENOXY)- 7-FLUORO-2-NAPHTHONITRILE (JLJ636) A NON-NUCLEOSIDE INHIBITOR
80, 4pwdB, 0.9663, 1.29, 0.992, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
81, 3v81B, 0.9663, 1.29, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
82, 1t05B, 0.9663, 1.29, 0.987, 414, 400, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
83, 3v81D, 0.9659, 1.29, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
84, 5tepB, 0.9656, 1.25, 0.985, 407, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ649) A NON-NUCLEOSIDE INHIBITOR
85, 4rw8B, 0.9655, 1.20, 0.985, 415, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR 
86, 3kleF, 0.9655, 1.32, 0.990, 419, 400, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
87, 2b6aB, 0.9653, 1.47, 0.988, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
88, 1s6pB, 0.9652, 1.51, 0.978, 427, 401, CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
89, 5fdlB, 0.9651, 0.67, 0.990, 396, 391, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH IDX899
90, 4b3oB, 0.9651, 1.19, 0.992, 410, 398, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
91, 4o44B, 0.9650, 1.48, 0.983, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-6-(3-MORPHOLINOPROPOXY)-135-TRIAZIN-2-YL)AMINO) BENZONITRILE (JLJ529) A NON-NUCLEOSIDE INHIBITOR
92, 1hquB, 0.9650, 1.61, 0.975, 430, 402, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
93, 5txpB, 0.9648, 1.38, 0.987, 412, 400, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
94, 4puoD, 0.9648, 1.32, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
95, 3klfF, 0.9643, 1.34, 0.990, 413, 400, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
96, 3kleB, 0.9642, 1.35, 0.990, 425, 400, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
97, 5txoB, 0.9641, 1.39, 0.987, 412, 400, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
98, 1rtdD, 0.9641, 1.35, 0.995, 414, 400, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
99, 5txnB, 0.9639, 1.40, 0.987, 412, 400, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
100, 6aocB, 0.9638, 1.45, 0.987, 425, 400, CRYSTAL STRUCTURE OF AN N-HYDROXYTHIENOPYRIMIDINE-2;4-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE 
101, 1s1wB, 0.9638, 1.41, 0.975, 404, 399, CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
102, 1hpzB, 0.9637, 1.64, 0.978, 430, 402, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
103, 5txlB, 0.9633, 1.41, 0.990, 411, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
104, 3klfB, 0.9633, 1.37, 0.990, 413, 400, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
105, 5txmB, 0.9632, 1.41, 0.990, 411, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
106, 6bsiB, 0.9631, 1.25, 0.992, 406, 398, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID CONTAINING THE POLYPURINE-TRACT SEQUENCE
107, 4r5pB, 0.9630, 1.43, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
108, 4puoB, 0.9630, 1.37, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
109, 1hniB, 0.9629, 1.55, 0.973, 427, 401, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
110, 3klfJ, 0.9628, 1.38, 0.992, 413, 400, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
111, 1hnvB, 0.9627, 1.53, 0.970, 427, 401, STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
112, 1bqmB, 0.9627, 1.60, 0.973, 430, 402, HIV-1 RT/HBY 097
113, 3v4iD, 0.9625, 1.41, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
114, 1uwbB, 0.9623, 1.54, 0.968, 427, 401, TYR 181 CYS HIV-1 RT/8-CL TIBO
115, 3v6dD, 0.9622, 1.39, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
116, 3v4iB, 0.9621, 1.44, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
117, 1tvrB, 0.9621, 1.54, 0.980, 427, 401, HIV-1 RT/9-CL TIBO
118, 4r5pD, 0.9618, 1.39, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
119, 3klgB, 0.9614, 1.46, 0.990, 413, 400, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
120, 5i42B, 0.9609, 1.46, 0.987, 412, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
121, 6bsgB, 0.9608, 1.12, 0.992, 404, 395, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN AN RNA HYDROLYSIS-OFF MODE
122, 1bqnB, 0.9607, 1.63, 0.965, 430, 402, TYR 188 LEU HIV-1 RT/HBY 097
123, 5hroD, 0.9605, 1.47, 0.990, 412, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
124, 5hroB, 0.9605, 1.48, 0.987, 412, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
125, 6bshB, 0.9603, 1.13, 0.992, 404, 395, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN THE RNA HYDROLYSIS MODE
126, 3v6dB, 0.9603, 1.49, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
127, 1vruB, 0.9603, 1.64, 0.992, 410, 400, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
128, 5txpD, 0.9602, 1.47, 0.987, 412, 400, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
129, 5i42D, 0.9602, 1.47, 0.987, 412, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
130, 4pquB, 0.9601, 1.38, 0.977, 412, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
131, 3klgF, 0.9601, 1.49, 0.992, 413, 400, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
132, 1revB, 0.9600, 1.65, 1.000, 412, 400, HIV-1 REVERSE TRANSCRIPTASE
133, 5txoD, 0.9599, 1.48, 0.987, 412, 400, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
134, 1fk9B, 0.9599, 1.31, 0.985, 403, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP- 266(EFAVIRENZ)
135, 5txnD, 0.9595, 1.49, 0.987, 412, 400, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
136, 3klfN, 0.9595, 1.45, 0.990, 413, 400, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
137, 4b3qB, 0.9593, 1.34, 0.992, 410, 398, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
138, 4dg1B, 0.9590, 1.53, 0.970, 418, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A
139, 5txlD, 0.9586, 1.50, 0.987, 412, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
140, 1vrtB, 0.9586, 1.40, 0.990, 401, 397, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
141, 5txmD, 0.9584, 1.51, 0.987, 412, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
142, 2ze2B, 0.9582, 1.69, 0.988, 416, 401, CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
143, 3ithB, 0.9581, 1.42, 0.950, 415, 398, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
144, 1lwcB, 0.9577, 1.37, 0.975, 402, 396, CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
145, 6dufB, 0.9574, 1.77, 0.985, 412, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE V106A/F227L MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
146, 1dtqB, 0.9572, 1.54, 1.000, 402, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 1 (PETT131A94)
147, 6cgfB, 0.9570, 1.67, 0.985, 414, 400, CRYSTAL STRUCTURE OF HIV-1 Y188L MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
148, 4o4gB, 0.9570, 1.72, 0.988, 428, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-135-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ527) A NON-NUCLEOSIDE INHIBITOR
149, 6c0jB, 0.9568, 1.67, 0.985, 414, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR K-5A2 
150, 3bgrB, 0.9567, 1.79, 0.990, 412, 401, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
151, 6c0lB, 0.9565, 1.67, 0.982, 414, 400, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
152, 4i2pB, 0.9564, 1.66, 0.990, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE
153, 3kk2B, 0.9563, 1.62, 0.993, 414, 401, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
154, 6c0oB, 0.9562, 1.68, 0.985, 412, 400, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
155, 1rtjB, 0.9560, 1.61, 0.997, 426, 400, MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
156, 1dttB, 0.9560, 1.36, 0.995, 412, 397, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 2 (PETT130A94)
157, 6eliB, 0.9558, 1.68, 0.987, 416, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE AND AN RNASE H INHIBITOR XZ462 
158, 6c0rB, 0.9558, 1.69, 0.985, 412, 400, CRYSTAL STRUCTURE OF HIV-1 K103N/Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
159, 6c0kB, 0.9558, 1.68, 0.985, 412, 400, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
160, 3dlkB, 0.9558, 1.45, 0.982, 409, 397, CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE RT69A
161, 4i2qB, 0.9557, 1.81, 0.988, 416, 401, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE
162, 6c0pB, 0.9556, 1.69, 0.982, 412, 400, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
163, 6c0nB, 0.9556, 1.69, 0.985, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR 25A 
164, 3klhB, 0.9555, 1.71, 0.983, 428, 402, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
165, 1lw2B, 0.9555, 1.36, 0.970, 406, 395, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
166, 1tl3B, 0.9552, 1.31, 0.980, 401, 394, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
167, 2oppB, 0.9549, 1.38, 0.977, 403, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
168, 1tl1B, 0.9549, 1.32, 0.980, 400, 394, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
169, 1r0aB, 0.9549, 1.72, 0.975, 429, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
170, 6duhB, 0.9547, 1.69, 0.985, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE Y181I MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
171, 1s1uB, 0.9547, 1.38, 0.975, 401, 395, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
172, 1tkzB, 0.9546, 1.33, 0.980, 401, 394, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576
173, 3kk1B, 0.9545, 1.60, 0.995, 412, 400, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
174, 2ic3B, 0.9545, 1.71, 0.967, 427, 400, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
175, 4kkoB, 0.9544, 1.81, 0.990, 412, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-METHOXY-6-(2-MORPHOLINOETHOXY)-135-TRIAZIN-2-YL)AMINO)-2-((3- METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513) A NON-NUCLEOSIDE INHIBITOR
176, 4g1qB, 0.9544, 1.71, 0.987, 416, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278 EDURANT) A NON-NUCLEOSIDE RT-INHIBITING DRUG
177, 4ig0B, 0.9543, 1.82, 0.988, 416, 401, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 507 SITE
178, 5c24B, 0.9542, 1.71, 0.990, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-68- DIMETHYLINDOLIZINE-2-CARBONITRILE (JLJ605) A NON-NUCLEOSIDE INHIBITOR
179, 1n6qB, 0.9540, 1.73, 0.985, 429, 402, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
180, 6dugB, 0.9539, 1.68, 0.985, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE K101P MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
181, 5hlfB, 0.9538, 1.60, 0.977, 416, 399, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
182, 2opqB, 0.9537, 1.35, 0.977, 400, 394, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
183, 6bsjB, 0.9534, 1.20, 0.990, 400, 393, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID SEQUENCE NON- PREFERRED FOR RNA HYDROLYSIS
184, 4iclB, 0.9533, 1.76, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE INCOMING DNTP BINDING SITE
185, 5cyqB, 0.9532, 1.73, 0.987, 415, 400, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-BROMOPYRAZOLE
186, 2hnyB, 0.9531, 1.36, 0.972, 401, 394, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
187, 3ig1B, 0.9530, 1.45, 0.980, 409, 396, HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
188, 3ithD, 0.9529, 1.63, 0.977, 415, 399, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
189, 1tktB, 0.9526, 1.32, 0.977, 399, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
190, 5d3gD, 0.9524, 1.59, 0.977, 410, 398, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
191, 1rt3B, 0.9524, 1.26, 0.990, 398, 393, AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
192, 1n5yB, 0.9524, 1.76, 0.985, 429, 402, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
193, 1lw0B, 0.9522, 1.33, 0.980, 399, 393, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
194, 5i3uD, 0.9521, 1.60, 0.980, 410, 398, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
195, 5i3uB, 0.9521, 1.69, 0.987, 416, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
196, 3qlhB, 0.9521, 1.62, 0.970, 407, 397, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
197, 1t03B, 0.9520, 1.77, 0.978, 429, 402, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
198, 5hp1D, 0.9519, 1.60, 0.977, 410, 398, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
199, 4we1B, 0.9519, 1.16, 0.982, 402, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ600)
200, 4ifvB, 0.9518, 1.77, 0.990, 412, 400, DETECTING ALLOSTERIC SITES OF HIV-1 REVERSE TRANSCRIPTASE BY X-RAY CRYSTALLOGRAPHIC FRAGMENT SCREENING
201, 1fkoB, 0.9518, 1.17, 0.987, 403, 392, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
202, 6aocD, 0.9516, 1.72, 0.987, 416, 400, CRYSTAL STRUCTURE OF AN N-HYDROXYTHIENOPYRIMIDINE-2;4-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE 
203, 4ig3B, 0.9515, 1.77, 0.987, 416, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT NEAR KNUCKLES SITE
204, 4idkB, 0.9514, 1.78, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 428 SITE
205, 5hp1B, 0.9513, 1.71, 0.987, 416, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
206, 4ifyB, 0.9513, 1.77, 0.990, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE KNUCKLES SITE
207, 5hlfD, 0.9512, 1.62, 0.977, 410, 398, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
208, 4pquD, 0.9511, 1.58, 0.982, 413, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
209, 2hnzB, 0.9510, 1.34, 0.975, 399, 393, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
210, 4id5B, 0.9507, 1.80, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE RNASE H PRIMER GRIP SITE
211, 3is9B, 0.9506, 1.87, 0.988, 416, 401, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 33 -(6-METHOXY-6-OXOHEX-1-ENE-11- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
212, 1c1cB, 0.9504, 1.37, 0.987, 416, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK- 6123
213, 4b3pB, 0.9503, 1.20, 0.992, 404, 392, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
214, 3kliB, 0.9499, 1.66, 0.952, 427, 399, CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
215, 2zd1B, 0.9499, 1.78, 0.990, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
216, 1c1bB, 0.9499, 1.44, 0.982, 415, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA- 186
217, 3kk3B, 0.9494, 1.53, 0.990, 407, 398, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
218, 5d3gB, 0.9493, 1.74, 0.987, 415, 400, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
219, 4zhrB, 0.9491, 1.42, 0.972, 409, 395, STRUCTURE OF HIV-1 RT Q151M MUTANT
220, 1rthB, 0.9491, 1.56, 0.990, 420, 397, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
221, 4kfbB, 0.9486, 1.83, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT NNRTI ADJACENT SITE
222, 3isnD, 0.9479, 1.71, 0.975, 415, 399, CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
223, 1s1tB, 0.9477, 1.38, 0.985, 416, 394, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
224, 1dloB, 0.9475, 1.69, 0.947, 415, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
225, 3qo9B, 0.9474, 1.95, 0.970, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
226, 5tuqB, 0.9469, 1.47, 0.980, 405, 394, CRYSTAL STRUCTURE OF A 6-CYCLOHEXYLMETHYL-3-HYDROXYPYRIMIDINE-24- DIONE INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
227, 5vqsB, 0.9468, 1.35, 0.972, 403, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON- NUCLEOSIDE INHIBITOR
228, 5c25B, 0.9468, 1.53, 0.985, 406, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 6- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-57-DIMETHYL-2- NAPHTHONITRILE (JLJ639) A NON-NUCLEOSIDE INHIBITOR
229, 4rw4B, 0.9468, 1.64, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103NY181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
230, 1qe1B, 0.9468, 1.71, 0.945, 415, 398, CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
231, 2iajB, 0.9467, 1.69, 0.962, 415, 398, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
232, 1rtiB, 0.9467, 1.36, 0.990, 413, 393, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
233, 1jlbB, 0.9466, 1.35, 0.987, 405, 393, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
234, 2hndB, 0.9458, 1.24, 0.979, 394, 390, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
235, 1rt7B, 0.9455, 1.43, 0.987, 415, 394, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
236, 1c0uB, 0.9453, 1.38, 0.990, 414, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934
237, 1rt6B, 0.9452, 1.38, 0.985, 414, 393, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
238, 1hvuK, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
239, 1hvuH, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
240, 1hvuE, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
241, 1hvuB, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
242, 1jlqB, 0.9451, 1.52, 0.987, 405, 394, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
243, 1jleB, 0.9451, 1.33, 0.987, 408, 392, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
244, 4rw7B, 0.9449, 1.67, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR
245, 3dokB, 0.9448, 1.33, 0.985, 402, 392, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
246, 3irxB, 0.9447, 1.99, 0.988, 416, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(37-DIMETHYL-2-OXO-23-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-134-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
247, 1hqeB, 0.9447, 1.71, 0.965, 415, 397, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
248, 1rt1B, 0.9446, 1.45, 0.985, 415, 394, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
249, 4rw9B, 0.9443, 1.69, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON- NUCLEOSIDE INHIBITOR
250, 5xn1B, 0.9442, 1.66, 0.967, 407, 397, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
251, 4rw6B, 0.9436, 1.70, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
252, 5xn0B, 0.9434, 1.68, 0.967, 407, 397, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
253, 1rt5B, 0.9429, 1.38, 0.990, 406, 392, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
254, 5cymB, 0.9427, 1.50, 0.980, 408, 393, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-IODOPYRAZOLE
255, 5xn0D, 0.9426, 1.67, 0.952, 407, 396, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
256, 4ko0B, 0.9421, 1.71, 0.975, 410, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135)
257, 1ep4B, 0.9420, 1.37, 0.995, 395, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- 1153
258, 5xn2B, 0.9419, 1.72, 0.967, 407, 397, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
259, 5j1eD, 0.9419, 1.45, 0.977, 393, 391, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
260, 5xn1D, 0.9418, 1.77, 0.972, 407, 397, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
261, 5vqzB, 0.9415, 1.42, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
262, 3dolB, 0.9415, 1.51, 0.985, 405, 394, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
263, 5vqwB, 0.9414, 1.42, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON-NUCLEOSIDE INHIBITOR
264, 5j2nB, 0.9414, 1.51, 0.992, 405, 393, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED EFDA-MP AT THE P-(POST-TRANSLOCATION) SITE AND DTMP AT THE N-(PRE- TRANSLOCATION) SITE
265, 5vquB, 0.9412, 1.43, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N- METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
266, 5vqvB, 0.9410, 1.43, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
267, 1klmB, 0.9410, 1.36, 0.987, 405, 391, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
268, 5vqyB, 0.9406, 1.44, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
269, 5vqxB, 0.9405, 1.44, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
270, 1jlcB, 0.9404, 1.26, 0.982, 402, 389, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
271, 5terB, 0.9401, 1.46, 0.990, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5- CHLORO-7-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-8-METHYL-2-NAPHTHONITRILE (JLJ651) A NON-NUCLEOSIDE INHIBITOR
272, 1s1xB, 0.9400, 1.33, 0.987, 397, 390, CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
273, 5xn2D, 0.9396, 1.81, 0.970, 407, 397, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
274, 1fkpB, 0.9396, 1.28, 0.987, 408, 389, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
275, 5vqrB, 0.9395, 1.41, 0.982, 400, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON- NUCLEOSIDE INHIBITOR
276, 5vqqB, 0.9392, 1.42, 0.982, 400, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N-METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
277, 5vqtB, 0.9391, 1.42, 0.982, 400, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 2- CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
278, 5j2pB, 0.9390, 1.35, 0.995, 400, 390, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED EFDA-MP AT THE P-(POST-TRANSLOCATION) SITE AND A SECOND EFDA-MP AT THE N-(PRE-TRANSLOCATION) SITE
279, 3dleB, 0.9390, 1.35, 0.990, 403, 390, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590.
280, 1jlgB, 0.9390, 1.41, 0.985, 405, 391, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
281, 1s1vB, 0.9383, 1.37, 0.985, 404, 390, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
282, 1jlfB, 0.9383, 1.43, 0.985, 404, 391, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
283, 1j5oB, 0.9381, 2.04, 0.953, 430, 401, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
284, 5uv5D, 0.9374, 1.38, 0.979, 393, 389, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
285, 1rt4B, 0.9374, 1.40, 0.990, 404, 390, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781
286, 1tkxB, 0.9371, 1.40, 0.987, 404, 390, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
287, 1jkhB, 0.9369, 1.35, 0.985, 398, 389, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
288, 1hmvH, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
289, 1hmvF, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
290, 1hmvD, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
291, 1hmvB, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
292, 1lweB, 0.9357, 1.53, 0.982, 401, 392, CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
293, 1hysB, 0.9349, 1.96, 0.952, 425, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
294, 2oprB, 0.9345, 1.34, 0.987, 400, 388, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
295, 1rt2B, 0.9338, 1.42, 0.979, 402, 389, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
296, 5j2qB, 0.9337, 1.36, 0.992, 400, 388, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED A MISMATCHED EFDA-MP AT THE N-(PRE-TRANSLOCATION) SITE
297, 2hmiB, 0.9337, 2.10, 0.958, 430, 401, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
298, 3kjvB, 0.9335, 1.30, 0.982, 400, 387, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
299, 1jlaB, 0.9335, 1.32, 0.987, 408, 387, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
300, 3dmjB, 0.9325, 1.28, 0.982, 401, 386, CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
301, 5j1eB, 0.9311, 1.62, 0.974, 405, 391, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
302, 1lwfB, 0.9300, 1.33, 0.982, 395, 386, CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
303, 2opsB, 0.9293, 1.46, 0.987, 409, 388, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
304, 5j2mB, 0.9292, 1.36, 0.995, 398, 386, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA AND EFDA-TRIPHOSPHATE A TRANSLOCATION-DEFECTIVE RT INHIBITOR
305, 3dm2B, 0.9288, 1.31, 0.987, 400, 385, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
306, 3dlgB, 0.9275, 1.34, 0.990, 400, 385, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
307, 5uv5B, 0.9249, 1.50, 0.984, 400, 386, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
308, 3hvtB, 0.9104, 1.79, 0.896, 398, 384, STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
309, 1mu2B, 0.9033, 2.28, 0.584, 402, 392, CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE
310, 6b19B, 0.8968, 2.10, 0.964, 399, 387, ARCHITECTURE OF HIV-1 REVERSE TRANSCRIPTASE INITIATION COMPLEX CORE 
311, 1c0tB, 0.8865, 1.08, 0.989, 373, 364, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326
312, 5ovnB, 0.8847, 2.56, 0.446, 405, 392, CRYSTAL STRUCURE OF FIV REVERSE TRANSCRIPTASE
313, 4kseB, 0.7582, 2.06, 0.962, 401, 319, CRYSTAL STRUCTURE OF A HIV P51 (219-230) DELETION MUTANT
314, 4ol8B, 0.6746, 4.80, 0.124, 447, 364, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
315, 4ol8F, 0.6547, 4.68, 0.129, 422, 350, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
